Zhang Q, Tao R, Li Z, Guo H, et al. A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma. Leuk Lymphoma 2022 Jul 19:1-4. doi: 10.1080/10428194.2022.2074985.
PMID: 35855547